Allurion launches gastric balloon for weight loss
Allurion, a company dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India - the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority of India overseen by the Ministry of Health & Family Welfare’s Directorate General of Health Services.
Dr.Shantanu Gaur founded Allurion with one goal: end
obesity. After completing his undergraduate studies at Harvard University, Dr.
Gaur founded the company while completing his medical studies at Harvard
Medical School in 2009. Together with his partner and former Harvard professor
Dr. Ram Chuttani, he developed the vision for the Allurion Program. At the core
of the Allurion Program is the Allurion Swallowable Capsule: the world’s first
and only swallowable, procedureless* gastric balloon for weight loss. The
Allurion Swallowable Capsule is paired with the Allurion Virtual Care Suite, a
remote patient monitoring solution powered by the Allurion Iris AI platform
that includes the Allurion Mobile App, Connected Scale and Health Tracker.
"As someone of Indian origin, India is a
special market for Allurion.It is part of my personal mission to bring our
revolutionary technology to India to help end obesity and diabetes,” says Dr
Shantanu Gaur, Founder and CEO of Allurion."Whether it is because they
have a wedding coming up, have steadily put on weight due to a busy or
stressful lifestyle, recently had a health scare, need to improve their
fertility, or need to lose weight before an operation, the Allurion Program can
be the answer for millions of patients throughout India,"he adds.
At the heart of the Allurion Program is the
Allurion’sVirtual Care Suite, which integrates the Allurion Mobile App,
Connected Scale, and Health Trackerinto a single “digital umbrella” to provide
remote patient monitoring, tele health and secure messaging with the care team.
The software platform is powered by artificial intelligence and machine
learning to allow care teams to interact with their patients– and their data.
The Allurion Programcan lead to 2.5 times more
weight loss compared to dietor exercise alone. More importantly, it works to
help patients make lifestyle changes that remain with them long after the
balloon is gone.
Dr Mohit Bhandari of MohakBariatrics is a bariatric
and endoscopic weight-loss surgeon, and a pioneer in offering the Allurion
Program in India.“Obesity is on the rise in India with three out of every four
urban Indians overweight. As one of the most experienced bariatric surgeons in
the Asia Pacific region with 17,000 bariatric surgeries performed to date, I
think that weight management needs to be normalized rather than stigmatized,
and the Allurion Program is a positive step in that direction, ”he says.
Dr Ram Chuttani, Chief Medical Officer and Founding
Partner of Allurion, adds: "Allurion is committed to provide patients a
best-in-class experience, and their safety is our top priority. Studies have
confirmed the proven efficacy and safety4 of the Allurion Program, helping
patients lose an average 10-15% of their body weight in approximately 16
weeks1.
Benoit Chardon, Chief Commercial Officer of Allurion
states: "Considering Allurion's success across markets – a result of the
perfect match between the benefits delivered by our program and patient
expectations – as well as the growing prevalence of obesity in India, we are
confident of the potential for success with our program in the country, where
our market research has shown that over a million obese people concerned and
ready to act about their weight would consider Allurion."
Comments
Post a Comment